The impact of the COVID-19 pandemic on diabetes-related mortality

2025-1-1

Validation of the Amharic Version of the Summary of Diabetes Self-Care Activity Scale among Type 2 Diabetes Patients in Addis Ababa, Ethiopia, 2023.

2024-10-1

Evaluation of a Support Tool for Diabetes Control in Primary Care – A Qualitative Study with Primary Care Staff

2024-10-1

Primary care monitoring of HbA1c tests in type 2 diabetic patients in Northern France and impact of the successive COVID-19 pandemic containments

2024-10-1

Diabetes in pregnancy: Anxious minds precarious times

2024-10-1

Assessment of Vitamin D Status in Obese and Non-obese Patients: A Case-control Study

2024-9-1

Epidemiology of Isolated Impaired Fasting Glucose among Asian Indians

2024-7-1

editorial board

2024-7-1

Contents

2024-7-1

The Correlation of ABC Goal Attainment with Insulin Resistance/Sensitivity in Syrian Type 2 Diabetes Patients.

2024-7-1

Predictive Factors of Diabetic Ketoacidosis in Patients with Newly Onset Type 1 Diabetes: A Single Center Study

2024-6-20

Anthropometric Measures of Obesity as Risk Indicators for Prediabetes. A Systematic Review and Meta-Analysis

2024-6-18

Ramadan fasting among adults with type 2 diabetes in five geographically different regions of the world: The DAR 2020 global survey

2024-6-1

The Association between Serum High-Density Lipoprotein and Hemoglobin A1c in T2DM: Evidence from a Nationwide Cross-Sectional Study in Diabetic Patients

2024-6-1

Hospital prevalence of diabetes mellitus among under 15 children in Butembo: a retrospective study at the University Clinics of Graben.

2024-4-22

Characteristics of Non-fasting Patients with Diabetes Type 2 in the DAR Global Surveys of 2020 and 2022

2024-4-7

Contents

2024-4-1

Editorial board

2024-4-1

Addressing Common Sources of Bias in Studies of New-Onset Type 2 Diabetes Following COVID that Use Electronic Health Record Data

2024-4-1

Paradoxical real-life underuse of GLP-1 receptor agonists in type 2 diabetes patients with atherosclerotic cardiovascular disease

2024-4-1

The Efficacy of a 24-Hour Preoperative Pause for SGLT2-Inhibitors in Type II Diabetes Patients Undergoing Bariatric Surgery to Mitigate Euglycemic Diabetic Ketoacidosis.

2024-4-1

Impact of timing of delivery for type 2 diabetes on perinatal outcomes

2024-4-1

“One-size-doesn't-fit-all” approach to diabetes prevention through lifestyle interventions

2024-4-1

Prevalence of anxiety and depression among pregnant women with diabetes and their predictors

2024-4-1

Oral Semaglutide Effectiveness and Safety in Real World Practice; the REVOLUTION Study

2024-4-1

Improving foot ulcer risk assessment and identifying associated factors: Results of an initiative enhancing diabetes care in primary settings

2024-4-1

Impact of the Sten-O Starter on Glycemic Management in Children and Adolescents with Type 1 Diabetes in the North Region of Denmark

2024-4-1

Phase angle associated is with low ankle-brachial index in type 2 diabetes patients in Ghana

2024-3-16

Association of Prediabetes with Stroke in Young Metabolically Healthy Tobacco Users: A Population-Based Analysis

2024-3-1

Early diagnosis of Charcot neuro-osteoarthropathy using MRI and its effect on patient outcomes: A seven-year retrospective audit

2024-3-1

Correlation of fasting C-peptide levels with abdominal adipose tissue thickness and pancreatic size amongst poorly controlled diabetic elderly patients

2024-2-9

Contents

2024-1-1

Evolution of the burden of diabetes among adults and children in Québec, Canada, from 2001 to 2019: A population-based longitudinal surveillance study

2024-1-1

Anxiety, depression and quality of life in relation to SARS-CoV-2 antibodies in individuals living with diabetes during the second wave of COVID-19

2024-1-1

Metabolic consequences of alterations in gut microbiota induced by antidiabetic medications

2024-1-1

Hypoglycemia avoidance behaviour in active Qatari adults with type 1 diabetes under blood glucose monitoring device

2024-1-1

Development and validation of a Type 1 and Type 2 diabetes-specific patient-reported experience measure e-questionnaire: Diabetes reported experience measures (DREMS)

2024-1-1

SOCIOECONOMIC STATUS AS DETERMINANT FOR THE DEVELOPMENT OF COMORBIDITIES IN ADULTS WITH TYPE 1 DIABETES: A NATIONWIDE REGISTER STUDY IN DENMARK FROM 1996-2018

2024-1-1

Platelet-rich plasma (PRP) as therapy for diabetic foot ulcer (DFU): A systematic review and meta-analysis of the latest randomized controlled trials

2024-1-1

Editorial Board

2024-1-1

Role of lowered level of serum vitamin D on diabetic foot ulcer and its possible pathomechanism: A systematic review, meta-analysis, and meta-regression

2024-1-1

Predictive modeling for the development of diabetes mellitus using key factors in various machine learning approaches

2024-1-1

Diabetic retinopathy prevalence in Mexico: Results from a primary public health access initiative for screening in patients with type 2 diabetes

2024-1-1

A comprehensive strategy of diabetic retinopathy screening in a public health system: identifying and overcoming obstacles for implementation

2024-1-1

Similar incidence of stroke with SGLT2 inhibitors and GLP-1 receptor agonists in real-world cohort studies among patients with type 2 diabetes

2024-1-1

Diabetes-induced cellular changes in the inner ear

2024-1-1

Anxiety, depression and quality of life in relation to SARS-CoV-2 antibodies in individuals living with diabetes during the second wave of COVID-19

2023-12-15

Real-life underuse of SGLT2 inhibitors for patients with type 2 diabetes at high cardiorenal risk

2023-10-18

Severe hypoglycemia and falls in older adults with diabetes: The Diabetes & Aging Study

2023-10-1

Association between abdominal obesity and diabetes in India: Findings from a nationally representative study

2023-10-1